Choices and tradeoffs: decreasing costs or improving hospital mortality rates
Tourangeau AE. Healthc Q. 2008; 11(1):23-4.
Publications
Health technology assessment in critical care
Scales DC, Laupacis A. Intensive Care Med. 2007; 33(12):2183-91. Epub 2007 Oct 20.
Cost and quality: evidence from Ontario long-term care hospitals
Wodchis WP, Teare GF, Anderson GM. Med Care. 2007; 45(10):981-8.
Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy
You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M. Am Heart J. 2007; 154(5):899-907.
The burden of asthma: can it be eased?
Gershon A, Wang C, Cicutto L, To T. Healthc Q. 2007; 10(1):22-4.
Effect of provider continuity on test repetition
van Walraven C, Cernat G, Austin PC. Clin Chem. 2006; 52(12):2219-28. Epub 2006 Oct 19.
Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative
Paterson JM, Laupacis A, Bassett K, Anderson GM; BC-Ontario Pharmacosurveillance for Decision-Making Collaborative. Health Aff. 2006; 25(5):1436-43.
Proliferation of cardiac technology in Canada: a challenge to the sustainability of Medicare
Alter DA, Stukel TA, Newman A. Circulation. 2006; 113(3):380-7.
Antipsychotic use in the elderly: shifting trends and increasing costs
Rapoport M, Mamdani M, Shulman KI, Herrmann N, Rochon PA. Int J Geriatr Psychiatry. 2005; 20(8):749-53.
The 2003 Canadian recommendations for dyslipidemia management: revisions are needed
Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A. CMAJ. 2005; 172(8):1027-31.